Overview

This apprenticeship role offers a unique opportunity to learn and work in a global healthcare consultancy company alongside a team of statisticians, psychometricians and programmers. In this full time role you will be working in project teams supporting statistical and psychometric analyses, and alongside you will be studying for a level 7 (masters) in Medical Statistics . 20% of your time will be dedicated towards study (3-year study period), with tuition fees fully paid for and a full-time salary.

Our statistical analyses involve the analysis of clinical trial data, with a focus on patient-centered outcomes such as quality of life, including how a patient is functioning, feeling or experiencing symptoms. Alongside more clinical measurements, such as blood pressure or survival time, these outcomes are used to inform healthcare decisions between different treatments. Our psychometric analyses are based around how we collect this data, including the creation of the outcome measures to be used in clinical trials and assessment of how reliable and valid they are within different patient populations.

Key requirements

• A highly numerate individual with a mathematics or mathematics with statistics bachelor’s degree (2:2 minimum) with an interest in applying statistics in the field of healthcare and medicine
• Highly organised, with a rational approach to problem solving
• A passion to learn
• Able to work in a team
• Good time management to balance work and study
• Eligible for a UK Government-approved level 7 (Masters) in Medical Statistics

How to apply

If you would like to learn more about this opportunity, including how to apply, please click here.

About Adelphi Values Patient-Centered Outcomes

Adelphi Values Patient-Centered Outcomes is a global leader in qualitative and quantitative research techniques to support the selection, development, evaluation and implementation of Clinical Outcome Assessments (COAs) for use in clinical studies and clinical practice. As a health outcomes consultancy we work with a wide range of pharmaceutical companies to support the evaluation of patient experience and assessment of treatment benefits. Our research puts the patient at the centre of drug development with the aim of improving patients’ lives by informing healthcare decisions.

In the past 12 months we have conducted approximately 400 studies, supported clients in the development and validation of nearly 200 outcome measures and our researchers have been authors on more than 65 scientific communications. This includes articles in peer-reviewed journals and presentations at international scientific conferences.